Edition 085 · 18 November 2026 · 2 min. read
Lower antibiotic use only creates value with transparent animal-health management
New UK antibiotic data show substantial progress, but they do not justify simplified quality messaging. According to official UK-VARSS surveillance, veterinary antibiotic sales rose by 2% between 2024 and 2025. At the same time, they remained 56% below their 2014 level. Use in poultry reared for meat reached its lowest recorded level, while pig use fell 11% year on year to its second-lowest level on record.
The report also states that antibiotics considered most important for treating serious infections in people account for less than 0.5% of sales for food-producing animals. Authorities describe resistance levels in livestock as substantially below historical levels. These are relevant indicators for animal health and supply-chain responsibility, but they are not, on their own, a product-quality guarantee.
For the meat industry, the operational message has two parts. First, lower use is sustainable only when prevention works: biosecurity, vaccination, diagnostics, hygiene, housing and management must reduce treatment need without delaying care for sick animals. Second, the figures need to retain their context. National sales data do not describe every farm, batch or product.
Communication with customers and consumers becomes more credible when it distinguishes responsible reduction, necessary therapeutic treatment and the absence of absolute claims. A serious approach is not “antibiotic-free at any price”; it is justified veterinary treatment, traceable records and learning from resistance data. For pork and poultry suppliers, this logic turns prudent medicine use from a reputational message into a documented discipline of quality and welfare.